Diffblue today announced the general availability of the Diffblue Testing Agent, an autonomous regression test generator that ...

Among patients with RCC, unselected for a known familial predisposition, 13.4% had P/LP variants. Almost half of patients with P/LP variants had a potentially targetable mutation. Targeted gene panel ...

Patients who have had a VUS through NGS that is predicted to cause abnormal splicing. Patients who want to prepare for prenatal/pre-implantation diagnosis and for predictive testing for individuals at ...